ANNALS OF CLINICAL AND LABORATORY SCIENCE, published by the Association of Clinical Scientists, is a pivotal journal in the fields of clinical biochemistry, hematology, immunology, and medical laboratory technology. Since its inception in 1971, this journal has become a vital resource for researchers and practitioners aiming to advance their knowledge and skills in laboratory sciences. Although currently not an open access journal, its rich repository of peer-reviewed articles and studies contributes significantly to the academic discourse in diagnostic and therapeutic practices. The journal is categorized in various quartiles, reflecting its impact and contributions to multiple scientific domains, such as Q4 in Clinical Biochemistry and Q3 in Pathology and Forensic Medicine as of 2023. With an extensive convergence of years up to 2024, it proves to be a timeless source for emerging trends and research innovations. The ANNALS OF CLINICAL AND LABORATORY SCIENCE not only supports the professional development of its readers but also encourages interdisciplinary collaboration, making it an essential tool for professionals, students, and researchers dedicated to improving health outcomes through advanced laboratory sciences.

The American Journal of Clinical Pathology, published by Oxford University Press Inc, stands as a vital resource in the fields of pathology and clinical medicine. With a rich history dating back to 1945 and an impressive impact factor reflected in its Q1 ranking in Pathology and Forensic Medicine, this journal serves as a cornerstone for researchers and professionals seeking to advance their knowledge and practice. Covering a breadth of topics within the discipline, it is recognized in 2023 as ranked #24 out of 208 in its category, highlighting its esteemed reputation within the scientific community. Although the journal does not currently offer open access, its rigorous peer-reviewed articles and cutting-edge research make it an essential addition to any academic or clinical library. The ISSN for print version is 0002-9173, with an E-ISSN of 1943-7722 available for digital access. Researchers, students, and practitioners alike will benefit from its comprehensive scope and commitment to disseminating high-quality scientific inquiry.

CYTOMETRY PART B-CLINICAL CYTOMETRY, published by Wiley, is a premier journal dedicated to advancing the field of cytometry with a specific focus on its clinical applications. With an impact factor reflective of its influential role in the scientific community, this journal serves as an essential resource for researchers, professionals, and students keen on exploring the latest developments in pathology, histology, and cell biology. The journal holds impressive rankings—Q1 in Pathology and Forensic Medicine and Q2 in Histology—illustrating its critical standing within the academic landscape. Covering a wide array of topics from clinical techniques to innovative applications in cytometry, it aims to disseminate high-quality research findings that contribute to enhanced diagnostic and therapeutic strategies. As an Open Access journal, it ensures that its valuable content reaches a broader audience, facilitating knowledge-sharing and fostering collaborations across interdisciplinary fields. Since its inception in 2002, CYTOMETRY PART B continues to shape the future of clinical cytometry, making significant contributions to both academia and clinical practice.

The Annals of Clinical Biochemistry, published by SAGE Publications Inc, is a prestigious journal that has been pivotal in advancing the field of clinical biochemistry since its inception. With an ISSN of 0004-5632 and an E-ISSN of 1758-1001, this journal provides a platform for high-quality, peer-reviewed research articles, reviews, and case studies that cover a wide range of topics, including biochemical analysis, diagnostic methodologies, and the latest advancements in clinical practices. As a recognized leader in the field, it holds a Q2 ranking in both Clinical Biochemistry and Miscellaneous Medicine categories, showcasing its contribution to the evolving landscape of medical science. The journal’s impact is further underscored by its strategic emphasis on fostering collaboration between researchers and healthcare professionals. Although it does not provide Open Access options, the accessible subscription model ensures that vital research remains within reach of academic and clinical institutions. The Annals of Clinical Biochemistry aims to promote the understanding and application of biochemical techniques in clinical settings, ensuring it remains an essential resource for researchers, professionals, and students alike.

Revista Romana de Medicina de Laborator is a prominent open-access journal published by SCIENDO, dedicated to the field of medical laboratory technology and biochemistry. Since its inception, this journal has been a vital platform for disseminating research findings and advancements in laboratory medicine. With an ISSN of 1841-6624 and E-ISSN 2284-5623, it has served the academic community since 2008 and has embraced an open-access model since 2013, ensuring that valuable research is accessible to all. While it features niche rankings in Scopus for areas such as Medical Laboratory Technology and Clinical Biochemistry, it consistently strives to engage researchers, professionals, and students. Its rich collection of articles highlights innovative techniques and methodologies, supporting the ongoing development of laboratory practices. Although its coverage in Scopus has been discontinued, the journal continues to publish high-quality studies that contribute significantly to the field, fostering knowledge exchange essential for advancing medical science.

JOURNAL OF CLINICAL LABORATORY ANALYSIS is a premier, peer-reviewed journal published by WILEY, focusing on the expansive field of laboratory medicine. With its ISSN 0887-8013 and E-ISSN 1098-2825, this open access journal has been serving the scientific community since 1987. As of 2023, it holds a notable impact in various domains, achieving category quartiles in Biochemistry, Clinical Biochemistry, Hematology, and more, showcasing its significance across multiple disciplines such as Medical Laboratory Technology and Public Health. Ranked impressively, it is placed 7th in Medical Laboratory Technology, reflecting its crucial role in advancing clinical practice and research. The journal aims to disseminate innovative research findings, methodologies, and reviews that can catalyze advancements in laboratory practices and improve patient outcomes. Accessible to a global audience since its transition to open access in 2019, the journal is not just limited to professionals but is also a valuable resource for students and researchers seeking to stay updated in this dynamic field. For more information, visit the journal's website.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, published by Taylor & Francis Ltd, stands as a premier journal in the field of clinical laboratory science, addressing pivotal advancements and challenges since its inception in 1970. With a commendable impact factor derived from its ranking in Q1 categories across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, and Clinical Biochemistry—this journal is a critical resource for researchers, clinicians, and educators aiming to deepen their understanding and application of laboratory science. The journal's rigorous peer-review process ensures that only the highest quality research is published, providing a platform for profound discussions that influence laboratory practices globally. Although not an open-access journal, it offers various subscription options to facilitate access to its wealth of knowledge. Operating out of Abingdon, England, CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES continues to shape the future of clinical biochemistry and laboratory research through its insightful articles, systematic reviews, and expert commentaries, making it an essential read for professionals eager to stay at the forefront of their field.

Journal of Mass Spectrometry and Advances in the Clinical Lab, published by Elsevier, serves as a premier resource within the fields of clinical biochemistry, medical laboratory technology, microbiology, and spectroscopy. Launched in 2021 with an Open Access model, this journal enhances the accessibility of innovative research, making it an ideal platform for researchers, practitioners, and students alike. With an impressive impact factor reflected in its quartile rankings—Q2 in Clinical Biochemistry and Microbiology, and Q1 in Medical Laboratory Technology and Spectroscopy—this journal ensures high visibility and credibility. The journal's diverse indexing and significant standings in Scopus rankings highlight its commitment to advancing knowledge and fostering collaboration among professionals in laboratory sciences. Endorsed by a robust editorial board comprising leading experts, the journal aims to disseminate cutting-edge findings and methodologies, contributing to significant advancements in clinical and scientific laboratory practices. By bridging theoretical frameworks and practical applications, this journal plays a crucial role in the continuous evolution of laboratory technologies, thereby empowering readers to push the boundaries of research and innovation in their fields.

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.